Skip to content
Biotechnology, Government VIC

MEDIA OPP: Launch of Bio Innovation Hub opens scope for new disease treatments

La Trobe University < 1 mins read

What:

Victorian Government Minister Colin Brooks, representing the Minister for Training and Skills Gayle Tierney, and La Trobe University Vice-Chancellor Professor Theo Farrell, will Launch the new $8 million state-of-the-art Bio Innovation Hub at La Trobe's Melbourne campus in Bundoora.

The purpose-built facility will support the development of world-leading biotechnology and agri-technology businesses. It includes PC2 “wet” laboratories – joining just a handful of the sought-after labs in the state – and world-class equipment to help businesses commercialise their research discoveries. 

 

VivaZome CEO and Managing Director Xenia Sango will outline the development of a new treatment that could potentially reverse or stop progression of traumatic brain injury, using the world-class facilities at the Hub.

The event also includes the official opening of the Jenny Graves Building, named in honour of eminent La Trobe Professor Jenny Graves AC.

 

When:

Friday, 12 July

Building launch 10am

Bio Innovation Hub launch 10.30am

Media to arrive 10 minutes before the launch start times

 

Where:

Level 2, Jenny Graves Building, La Trobe University, Bundoora

See Map for details. Parking is recommended in CP1 or CPV

 

Media enquiries

Robyn Grace I r.grace@latrobe.edu.au I M: 0420826595

Charisse Ede I c.ede@latrobe.edu.au I M: 0404030698

 

More from this category

  • Biotechnology
  • 21/01/2025
  • 10:39
OncoSil Medical Limited (ASX:OSL)

OncoSil Medical Appoints Lel Smits as Non-Executive Director

Pancreatic cancer treatment device companyOncoSil Medical Limited (ASX:OSL) has announced the appointment of Ms. Lel Smits as a NonExecutive Director to the Board of OncoSil Medical, effective immediately. Ms. Smits brings a wealth of expertise in governance, strategy, risk oversight, and corporate communications, with a distinguished career advising over 500 ASX-listed management teams and Boards. Ms.Smits is an award-winning entrepreneur and director, recognised as Director of the Year by Women in Finance in both 2024 and 2022. Since 2021, she has served as a Director on the Board of Australian Shareholders' Association. Her extensive career began as a finance journalist,…

  • Biotechnology
  • 21/01/2025
  • 08:42
OncoSil Medical Limited (ASX:OSL)

OncoSil Medical Appoints Lel Smits as Non-Executive Director

Pancreatic cancer treatment device companyOncoSil Medical Limited (ASX:OSL) has announced the appointment of Ms. Lel Smits as a NonExecutive Director to the Board of OncoSil Medical, effective immediately. Ms. Smits brings a wealth of expertise in governance, strategy, risk oversight, and corporate communications, with a distinguished career advising over 500 ASX-listed management teams and Boards. Ms.Smits is an award-winning entrepreneur and director, recognised as Director of the Year by Women in Finance in both 2024 and 2022. Since 2021, she has served as a Director on the Board of Australian Shareholders' Association. Her extensive career began as a finance journalist,…

  • Biotechnology
  • 13/01/2025
  • 23:40
X4 Pharmaceuticals

X4 Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize Mavorixafor in Europe, Australia, and New Zealand

X4 to receive a €28.5 million upfront payment and up to €226 million in potential regulatory and commercial milestone payments in addition to tiered, double-digit royalties up to the mid-twentiesUpfront non-dilutive funds strengthen X4’s balance sheet as enrollment ramps up in the company’s global Phase 3 clinical trial in chronic neutropenia Agreement underscores Norgine’s commitment to bring transformative therapies to patients in need in these key strategic territoriesBOSTON and UXBRIDGE, United Kingdom, Jan. 13, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, and Norgine,…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.